Showing 61-80 of 1273 for: Cochrane Systematic Reviews > Special categories 
- Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis
Cochrane Systematic Reviews, 12-May-2010
Pancreatic necrosis may complicate severe acute pancreatitis, and is detectable by computed tomography (CT). If it becomes infected mortality increases, but the use of prophylactic antibiotics raises concerns about antibiotic resistance and fungal infecti
- Antibiotic treatment for travellers' diarrhoea
Cochrane Systematic Reviews, 24-Jul-2000
Using a pilot system we have categorised this review as: Current question - update pending (See "Published notes" section for an explanation).
- Antibiotic use for irreversible pulpitis
Cochrane Systematic Reviews, 30-May-2019
Irreversible pulpitis, which is characterised by acute and intense pain, is one of the most frequent reasons that patients attend for emergency dental care. Apart from removal of the tooth, the customary way of relieving the pain of irreversible pulpitis
- Antibiotics for incomplete abortion
Cochrane Systematic Reviews, 16-Apr-2008
Unsafe abortions result not only in costs for acute care but may also be responsible for longer-term complications such as pelvic inflammatory disease, damage to reproductive organs, and secondary infertility. If effective, antibiotic prophylaxis at the t
- Antibiotics for preventing recurrent urinary tract infection in non‐pregnant women
Cochrane Systematic Reviews, 19-Jul-2004
Urinary tract infection (UTI) is a common health care problem. Recurrent UTI (RUTI) in healthy non-pregnant women is defined as three or more episodes of UTI during a twelve month period. Long-term antibiotics have been proposed as a prevention strategy f
- Antibiotics for the prophylaxis of bacterial endocarditis in dentistry
Cochrane Systematic Reviews, 3-Oct-2013
Infective endocarditis is a severe infection arising in the lining of the chambers of the heart with a high mortality rate.
- Antibiotics for treating acute chest syndrome in people with sickle cell disease
Cochrane Systematic Reviews, 18-Sep-2019
The clinical presentation of acute chest syndrome is similar whether due to infectious or non-infectious causes, thus antibiotics are usually prescribed to treat all episodes. Many different pathogens, including bacteria, have been implicated as causative
- Antibiotics versus placebo for prevention of postoperative infection after appendicectomy.
Cochrane Systematic Reviews, 20-Jul-2005
Appendicitis is the most common cause of acute abdominal pain requiring surgical intervention. The cause of appendicitis is unclear and the mechanism of pathogenesis continues to be debated. Despite improved asepsis and surgical techniques, postoperative
- Anticholinergic drugs for wheeze in children under the age of two years
Cochrane Systematic Reviews, 20-Jul-2005
Wheeze in infancy and early childhood is common and appears to be increasing though the magnitude of any increase is unclear. Most wheezing episodes in infancy are precipitated by respiratory viral infections. Treatment of very young children with wheeze
- Anticholinergic drugs versus other medications for overactive bladder syndrome in adults
Cochrane Systematic Reviews, 17-Oct-2007
Overactive bladder syndrome is defined as "urgency with or without urge incontinence, usually with frequency and nocturia". It is a common condition with significant economic and quality of life implications. While the condition's pathophysiology remains
- Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
Cochrane Systematic Reviews, 7-May-2014
Anticoagulant treatment for intermittent claudication might improve functional capacity and prevent acute cardiovascular complications caused by peripheral obstructive arterial disease. This is an update of the review first published in 2001.
- Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
Cochrane Systematic Reviews, 13-May-2008
Venous thromboembolism (VTE) is the term given to any thromboembolic event (blocking of a blood vessel by a blood clot) occurring in the venous system. The current treatment recommended for VTE is anticoagulation (reduction of the blood's ability to clot)
- Anticoagulation for people with cancer and central venous catheters
Cochrane Systematic Reviews, 1-Jun-2018
Central venous catheter (CVC) placement increases the risk of thrombosis in people with cancer. Thrombosis often necessitates the removal of the CVC, resulting in treatment delays and thrombosis-related morbidity and mortality. This is an update of the Co
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
Cochrane Systematic Reviews, 8-Dec-2021
Compared with people without cancer, people with cancer who receive anticoagulant treatment for venous thromboembolism (VTE) are more likely to develop recurrent VTE.
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
Cochrane Systematic Reviews, 19-Jun-2018
Cancer increases the risk of thromboembolic events, especially in people receiving anticoagulation treatments.
- Anticoagulation versus placebo for heart failure in sinus rhythm
Cochrane Systematic Reviews, 18-May-2021
People with chronic heart failure (HF) are at risk of thromboembolic events, including stroke, pulmonary embolism, and peripheral arterial embolism; coronary ischaemic events also contribute to the progression of HF. The use of long-term oral anticoagulat
- Anticonvulsant drugs for acute and chronic pain
Cochrane Systematic Reviews, 3-Sep-2009
Anticonvulsant drugs have been used in the management of pain since the 1960s. The clinical impression is that they are useful for chronic neuropathic pain, especially when the pain is lancinating or burning. Readers are referred to reviews of carbamazepi
- Antidepressants for neuropathic pain
Cochrane Systematic Reviews, 27-Jan-2014
This is an updated version of the original Cochrane review published in Issue 3, 2005 of The Cochrane Library
. For many years antidepressant drugs have been used to manage neuropathic pain, and are often the first choice treatment. It is not clear, howev
- Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis
Cochrane Systematic Reviews, 23-May-2016
Depression affects approximately one-quarter of people treated with dialysis and is considered an important research uncertainty by patients and health professionals. Treatment for depression in dialysis patients may have different benefits and harms comp
- Antidepressants versus placebo for the depressed elderly
Cochrane Systematic Reviews, 22-Jan-2001
Depression warranting intervention is found in ten percent of people over the age of 60. Older depressed people are more likely to die than non-depressed. Relatively few receive therapeutic interventions, and those that do, tend to receive low dose antide
